Midsona

11,85 SEK

-10,57%

Mindre end 1K følgere

MSON B

NASDAQ Stockholm

Food & Beverage

Consumer Goods & Services

-10,57 %
+3,04 %
+29,93 %
+39,74 %
+42,77 %
+24,21 %
+41,24 %
-85,48 %
-50,66 %

Midsona operates in the health and wellness industry and focuses on the manufacture and distribution of dietary supplements and health products. The company's products are aimed at individuals and retailers looking for healthy alternatives. The business is global with a primary presence in Europe. Midsona was founded in 1892 and is headquartered in the city of Malmö, Sweden.

Læs mere
Markedsværdi
1,72 mia. SEK
Aktieomsætning
12,88 mio. SEK
Omsætning
3,63 mia.
EBIT %
1,6 %
P/E
169,29
Udbytteafkast, %
1,86 %
Omsætning og EBIT-margin

Omsætning mia.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
6.5
2026

Generalforsamling '26

7.5
2026

Årligt udbytte

17.7
2026

Delårsrapport Q2'26

Eksterne analyser

Midsona: Margins over matter - ABG

* Adj. EBIT well above estimates at SEK 45m * Underlying performance strong, but keep an eye out for ME conflict * Consensus adj. EBIT revisions likely up low-single-digits A beat where it matters The Q1 report was slightly softer than expected on sales...

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Eksterne analyser

Midsona: Skipping down Sesame Street - ABG

* Q1e: flat organic growth and minor margin improvements * Risenta acquisition adds 3.5% to FY sales * Trading at '26e EV/EBITA of ~9.5x We expect a fairly uneventful Q1 We anticipate flat organic growth y-o-y in Q1'26e, implying sales of SEK 909m and...

Eksterne analyser

Midsona: Brighter days ahead - ABG

* Underlying performance indicative of a brighter '26e * '26e-'27e adj. EBITA up 5% * Trading at NTM EV/EBITA of 8x Solid underlying performance boosted by NRIs Q4 came in above expectations on all key items, but was especially strong on adj. EBIT (29...

Eksterne analyser

Midsona: Closing the year in style - ABG

* Adj. EBIT 29% above estimates at SEK 47m * '26e could bring both organic and structural growth * Consensus EBIT revisions likely up h.s.d. Q4'25 report The Q4 report was materially better than expected on adj. EBIT. Sales amounted to SEK 933m (2% vs...

Eksterne analyser

Midsona: Persistent earnings despite soft sales - ABG

* Q4e: soft growth, but margins supported by restructuring programme* Estimate cuts on FX and product mix* Trading at '26e EV/EBITA of ~7.5xWhat to expect in Q4'25eWe anticipate -1% y-o-y organic growth in Q4'25e, implying sales of SEK 918m and adj. ...

Eksterne analyser

Midsona: Feedback from ABGSC Investor Days - ABG

* Strong potential for margin improvements* Short term priorities presented* Favourable sales mix is the key driver for 8% margin Well-positioned in a recovering market Today, we welcomed Midsona's new CEO, Henrik Hjalmarsson, to ABGSC's Investor Days...